Similar to Cbl-c, the tumors with the most frequent mutations in Cbl and Cbl-b were again melanoma, endometrial cancer, colorectal cancer, and non-small cell lung cancer (S1 Table and S2 Table). This evidence concerns the gene CBLC and non-small cell lung carcinoma.